Explore All 241 Secondary Buyout Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | December 3, 2019 |
| Target | Ondal Group |
| Sector | Medical Products |
| Buyer(s) | IK Partners |
| Sellers(s) | Capvis |
| Deal Type | Secondary Buyout |
| Advisor(s) | William Blair (Financial) Hengeler Mueller (Legal) |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1989 |
| PE ASSETS | 14.0B EUR |
| Size | Mega |
| Type | Sector Agnostic |
IK Partners is a private equity firm that targets control investments in lower middle-market to large-sized companies throughout Europe. IK focuses on growth businesses located in the Benelux region, as well as Denmark, Finland, France, Germany, Norway and Sweden. The Firm looks to commit €10 to €300 million of equity capital per transaction and targets companies with strong cash-flows. IK Investment Partners was formerly known as Industry Kapital. IK Partners was formed in 1989 and is based in London, England.
| Deal Context for Buyer | # |
|---|---|
| Overall | 135 of 195 |
| Sector: Medical Products | 7 of 7 |
| Type: Secondary Buyout | 46 of 74 |
| Country: Germany | 20 of 29 |
| Year: 2019 | 7 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-11-26 |
Mabtech
Nacka Strand, Sweden Mabtech is a biotech company specialising in immune monitoring products used by companies and researchers on a global scale. Mabtech was founded in 1986 and is based in Nacka Strand, Sweden. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-12-19 |
Cerelia
Paris, France Cerelia is a provider of innovative bakery solutions with a product portfolio including ready-to-bake pie and pizza dough, pancakes, crepes, and cookies. Cerelia was founded in 1999 and is based in Paris, France. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1990 |
| PE ASSETS | 3.9B EUR |
| Size | Large |
| Type | Sector Agnostic |
Capvis Equity Partners is a Swiss-based private equity firm focused on buyout, succession, and expansion investments in Switzerland, China, and Germany. Sectors of interest include Healthcare, Industrial Technology, and Advanced Services & Software. Capvis will consider both majority and minority positions. The Firm's investment horizon is four to six years. Capvis Equity Partners was formed in 1990 and is headquartered in Baar with additional offices in Germany and China.
| Deal Context for Seller | # |
|---|---|
| Overall | 32 of 35 |
| Sector: Medical Products | 2 of 2 |
| Type: Secondary Buyout | 7 of 8 |
| Country: Germany | 7 of 8 |
| Year: 2019 | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-05-15 |
Xovis
Zollikofen, Switzerland Xovis is a provider of sensor-based people flow solutions that combine 3D stereovision sensors with software for counting, tracking, and analyzing how people move through spaces such as airports, retail environments, public transportation hubs, and smart buildings. Xovis was founded in 2008 and is based in Zollikofen, Switzerland. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-12-13 |
Tertianum
Zurich, Switzerland Tertianum is a provider of housing and care services for older adults, offering senior residences, assisted living apartments, and nursing care tailored to individual needs. The Company’s services include accommodation options with various support levels, medical care, and community activities. Tertianum was founded in 1982 and is based in Zurich, Switzerland. |
Buy | - |